{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:55:35Z","timestamp":1767999335550,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose positron emission tomography\/computed tomography (<jats:sup>18<\/jats:sup>F-FDG PET\/CT) has been investigated in extremity sarcomas, there is no evidence on its usefulness in retroperitoneal sarcoma. This study was designed to evaluate the usefulness of <jats:sup>18<\/jats:sup>F-FDG PET\/CT in predicting aggressiveness of retroperitoneal liposarcoma. Patients experienced surgery for retroperitoneal liposarcoma from November 2007 to February 2018 and underwent preoperative <jats:sup>18<\/jats:sup>F-FDG PET\/CT were included. Preoperative maximum standardized uptake value (SUV<jats:sub>max<\/jats:sub>) was calculated. To evaluate the predictability of SUV<jats:sub>max<\/jats:sub> for F\u00e9d\u00e9ration Nationale des Centres de Lutte Contre le Cancer (FNCLCC) grade 3, receiver operating characteristics (ROC) curve analysis was performed. To analyze whether SUV<jats:sub>max<\/jats:sub> can be a risk factor for prognosis, multivariable Cox regression was performed including potential risk factors regarding operation and histopathology. A total of 133 patients were included. ROC curve showed area under the curve of 0.877 (P\u2009&lt;\u20090.001), with a cut-off point of 4.5 SUV<jats:sub>max<\/jats:sub> showing 85.7% sensitivity and 78.3% specificity. Cox analyses showed that SUV<jats:sub>max<\/jats:sub>\u2009&gt;\u20094.5 was a significant factor for recurrence-free survival (HR\u2009=\u20092.148, CI 1.301\u20133.546, P\u2009=\u20090.003) and overall survival (HR\u2009=\u20095.052, CI 1.854\u201313.766, P\u2009=\u20090.002). SUV<jats:sub>max<\/jats:sub> is highly predictive of FNCLCC grade 3 and SUV<jats:sub>max<\/jats:sub>\u2009&gt;\u20094.5 can be used as a prognostic factor before obtaining the histopathology.<\/jats:p>","DOI":"10.1038\/s41598-019-43215-5","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T13:52:08Z","timestamp":1556545928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography\/computed tomography improves outcome prediction in retroperitoneal liposarcoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Jinsoo","family":"Rhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hyup","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Jun","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyo Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Berm","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"key":"43215_CR1","doi-asserted-by":"crossref","unstructured":"Das Gupta, T. K. Tumors and tumor-like conditions of the adipose tissue. Current problems in surgery, 1\u201360 (1970).","DOI":"10.1016\/S0011-3840(70)80010-7"},{"key":"43215_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF00199383","volume":"427","author":"T Mentzel","year":"1995","unstructured":"Mentzel, T. & Fletcher, C. D. Lipomatous tumours of soft tissues: an update. Virchows Archiv: an international journal of pathology 427, 353\u2013363 (1995).","journal-title":"Virchows Archiv: an international journal of pathology"},{"key":"43215_CR3","first-page":"10","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA: a cancer journal for clinicians 62, 10\u201329 (2012).","journal-title":"CA: a cancer journal for clinicians"},{"key":"43215_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1200\/JCO.2008.18.0802","volume":"27","author":"S Bonvalot","year":"2009","unstructured":"Bonvalot, S. et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 27, 31\u201337 (2009).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"43215_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1200\/JCO.2008.17.8871","volume":"27","author":"A Gronchi","year":"2009","unstructured":"Gronchi, A. et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 27, 24\u201330 (2009).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"43215_CR6","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1200\/JCO.2012.44.3747","volume":"31","author":"A Gronchi","year":"2013","unstructured":"Gronchi, A. et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 31, 1649\u20131655 (2013).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"43215_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/annonc\/mdt576","volume":"25","author":"M Toulmonde","year":"2014","unstructured":"Toulmonde, M. et al. Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Annals of oncology: official journal of the European Society for Medical Oncology\/ESMO 25, 730\u2013734 (2014).","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology\/ESMO"},{"key":"43215_CR8","doi-asserted-by":"publisher","first-page":"e7537","DOI":"10.1097\/MD.0000000000007537","volume":"96","author":"J Rhu","year":"2017","unstructured":"Rhu, J. et al. Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening. Medicine 96, e7537 (2017).","journal-title":"Medicine"},{"key":"43215_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/BF02573869","volume":"9","author":"JJ Jones","year":"2002","unstructured":"Jones, J. J. et al. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol 9, 346\u2013354 (2002).","journal-title":"Ann Surg Oncol"},{"key":"43215_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/jso.24135","volume":"113","author":"A Kirane","year":"2016","unstructured":"Kirane, A. & Crago, A. M. The importance of surgical margins in retroperitoneal sarcoma. J Surg Oncol 113, 270\u2013276 (2016).","journal-title":"J Surg Oncol"},{"key":"43215_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/1758834017705588","volume":"9","author":"S Pasquali","year":"2017","unstructured":"Pasquali, S. & Gronchi, A. Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications. Ther Adv Med Oncol 9, 415\u2013429 (2017).","journal-title":"Ther Adv Med Oncol"},{"key":"43215_CR12","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1200\/JCO.2004.01.040","volume":"22","author":"PW Pisters","year":"2004","unstructured":"Pisters, P. W. et al. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol 22, 3375\u20133380 (2004).","journal-title":"J Clin Oncol"},{"key":"43215_CR13","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.juro.2006.12.006","volume":"177","author":"CJ Chouairy","year":"2007","unstructured":"Chouairy, C. J., Abdul-Karim, F. W. & MacLennan, G. T. Retroperitoneal liposarcoma. The Journal of urology 177, 1145 (2007).","journal-title":"The Journal of urology"},{"key":"43215_CR14","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2967\/jnumed.108.053694","volume":"49","author":"MR Benz","year":"2008","unstructured":"Benz, M. R. et al. Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 49, 1579\u20131584 (2008).","journal-title":"Journal of nuclear medicine: official publication, Society of Nuclear Medicine"},{"key":"43215_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/CCO.0b013e32832c95e2","volume":"21","author":"MR Benz","year":"2009","unstructured":"Benz, M. R. et al. Utilization of positron emission tomography in the management of patients with sarcoma. Current opinion in oncology 21, 345\u2013351 (2009).","journal-title":"Current opinion in oncology"},{"key":"43215_CR16","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s00259-012-2159-z","volume":"39","author":"HM Fuglo","year":"2012","unstructured":"Fuglo, H. M., Jorgensen, S. M., Loft, A., Hovgaard, D. & Petersen, M. M. The diagnostic and prognostic value of (1)(8)F-FDG PET\/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients. European journal of nuclear medicine and molecular imaging 39, 1416\u20131424 (2012).","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"43215_CR17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.sla.0000152663.61348.6f","volume":"241","author":"MH Schwarzbach","year":"2005","unstructured":"Schwarzbach, M. H. et al. Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas. Annals of surgery 241, 286\u2013294 (2005).","journal-title":"Annals of surgery"},{"key":"43215_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-018-0095-9","volume":"8","author":"RE Macpherson","year":"2018","unstructured":"Macpherson, R. E. et al. Retrospective audit of 957 consecutive (18)F-FDG PET-CT scans compared to CT and MRI in 493 patients with different histological subtypes of bone and soft tissue sarcoma. Clin Sarcoma Res 8, 9 (2018).","journal-title":"Clin Sarcoma Res"},{"key":"43215_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/jso.23523","volume":"109","author":"SR Skamene","year":"2014","unstructured":"Skamene, S. R. et al. Metabolic activity measured on PET\/CT correlates with clinical outcomes in patients with limb and girdle sarcomas. J Surg Oncol 109, 410\u2013414 (2014).","journal-title":"J Surg Oncol"},{"key":"43215_CR20","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1007\/s00259-013-2680-8","volume":"41","author":"D Andreou","year":"2014","unstructured":"Andreou, D. et al. Prognostic relevance of (1)(8)F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-alpha and melphalan. European journal of nuclear medicine and molecular imaging 41, 1076\u20131083 (2014).","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"43215_CR21","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1007\/s00259-013-2511-y","volume":"40","author":"ES Choi","year":"2013","unstructured":"Choi, E. S. et al. Total lesion glycolysis by 18F-FDG PET\/CT is a reliable predictor of prognosis in soft-tissue sarcoma. European journal of nuclear medicine and molecular imaging 40, 1836\u20131842 (2013).","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"43215_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2967\/jnumed.114.152462","volume":"56","author":"WP Fendler","year":"2015","unstructured":"Fendler, W. P. et al. PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 56, 530\u2013537 (2015).","journal-title":"Journal of nuclear medicine: official publication, Society of Nuclear Medicine"},{"key":"43215_CR23","doi-asserted-by":"crossref","unstructured":"Rhu, J. et al. Radical Nephrectomy for Primary Retroperitoneal Liposarcoma Near the Kidney has a Beneficial Effect on Disease-Free Survival. World journal of surgery (2017).","DOI":"10.1007\/s00268-017-4157-6"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43215-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43215-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43215-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:02:04Z","timestamp":1671267724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43215-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["43215"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-43215-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"20 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6605"}}